Author

Cailing Yin

Cincinnati Children's Hospital Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Organism:human· 3 Approach:statistical model· 3 Assay:ChIP-seq· 2 Research Focus:gene regulatory network inference· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Matthew T. WeirauchiD· 4 shared Andrew VonHandorfiD· 3 shared Arame A. DioufiD· 3 shared Carmy R. ForneyiD· 3 shared Katelyn A. Dunn· 3 shared Leah Claire KottyaniD· 3 shared Lee EdsalliD· 3 shared Lucinda P. LawsoniD· 3 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetic & Genomic Medicine

Matthew T. WeirauchORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genome

Phillip J. Dexheimer, Matthew R. Hass, Lee Edsall, Arame A. Diouf, Sydney H Jones, Omer Donmez, Cailing Yin, Katelyn A. Dunn, Carmy R. Forney, Hayley K. Hesse, Andrew VonHandorf, Xiaoting Chen, Sreeja Parameswaran, Olivia E. Gittens, Kenyatta C. M. F. Viel, , Matthew T. Weirauch

This study systematically investigates EBV transcriptional regulators' interactions with the human genome, identifying extensive gene expression alterations and chromatin changes.

Cell Genomics · Jul 15, 2026Peer-reviewedGenomics

Enhanced EBNA2-dependent activity in EBV-transformed B cells from patients with multiple sclerosis

Marissa Granitto, Ellie Kim, Carmy R. Forney, Cailing Yin, Arame A. Diouf, Andrew VonHandorf, Phillip J. Dexheimer, Sreeja Parameswaran, Xiaoting Chen, Omer A. Donmez, Hope Rowden, Casey O. Swoboda, Molly Shook, Katelyn A. Dunn, Hania Kébir, , Matthew T. Weirauch

This study shows that EBNA2 activity is increased in MS patients, altering gene expression and chromatin accessibility in EBV-transformed B cells.

medRxiv · Mar 9, 2026 · PreprintGenetic & Genomic Medicine

Comparison of PU.1 genomic binding across immune cells reveals cell type-specific roles in autoimmune disease

David A. Lewis, Molly Shook, Lucinda P. Lawson, Sreeja Parameswaran, Xiaoting Chen, Lee Edsall, Omer A. Donmez, Cailing Yin, Diego A. Rosado‐Tristani, Andrew VonHandorf, Phillip J. Dexheimer, Carmy R. Forney, Jennifer M. Felton, Arame A. Diouf, Katelyn A. Dunn, , Leah Claire Kottyan

medRxiv · Jan 27, 2026 · PreprintGenetic & Genomic Medicine

Integrative Multi-Omics Analysis Identifies Nuclear Factor I as a Key Driver of Dysregulated Purine Metabolism in DIPG

Ian Mersich, Sunny Congrove, Matthew J. Horchar, Román Cáceres, Ranjithmenon Muraleedharan, Janki M. Desai, Pankaj B. Desai, Larry Sallans, Julie A. Reisz, Abby Grier, Matthew R. Hass, Omer Donmez, Cailing Yin, Matthew T. Weirauch, Leah Claire Kottyan, , Biplab Dasgupta

This study identifies nuclear factor I (NFI) as a driver of dysregulated purine metabolism in DIPG, showing that targeting ATIC reduces tumor progression in mice.

bioRxiv · May 21, 2025 · PreprintCancer Biology